Drugs Made In America Acquisition Corp.
Recent Filings
All 57 filings →| Form | Description | Date |
|---|---|---|
| PRE 14A | PROXY STATEMENT | Mar 27, 2026 |
| 8-K | CURRENT REPORT | Mar 27, 2026 |
| 8-K | CURRENT REPORT | Mar 6, 2026 |
| 8-K | CURRENT REPORT | Mar 6, 2026 |
| 10-Q | QUARTERLY REPORT | Nov 18, 2025 |
| 8-K | CURRENT REPORT | Nov 18, 2025 |
| NT 10-Q | NOTIFICATION OF LATE FILING | Nov 17, 2025 |
| SCHEDULE 13G/A | — | Nov 12, 2025 |
| 10-Q | QUARTERLY REPORT | Aug 14, 2025 |
| SCHEDULE 13G/A | — | Aug 14, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition LLC | — | Purchase | 30,000 | 4,188,780 | Feb 18, 2025 |
| Stockwell Lynn | CEO and Exe. Chair of Board | Purchase | 30,000 | 4,188,780 | Feb 18, 2025 |
| Stockwell Lynn | CEO and Executive COB | Purchase | 400,000 | 10,257 | Jan 29, 2025 |